PTH and chronic kidney disease: High levels of circulating OCN and uOCN were observed in CKD patients (50–52), potentially due to increased bone metabolism, decreased renal clearance or both, with progression correlating with serum intact PTH and alkaline phosphatase (ALP) (50, 51), most probably reflecting the severity of the underlying bone disorder.